In a blog published March 29 by Health Affairs, four researchers expressed the need for creative reimbursement systems to “promote accountability” for outcomes related to devices that treat cardiovascular disease (CVD).

Death rates from heart disease decreased by 68 percent for Americans from 1968 to 2015, according to a new analysis, but the mortality decline was greater for whites than blacks.

Diagnosed diabetes in the U.S. cost a total of $327 billion in 2017, according to a new report commissioned by the American Diabetes Association published online March 22 in Diabetes Care.

The American Heart Association (AHA) issued a statement March 29 applauding Congress for including funding increases for federal programs aimed at combating cardiovascular disease in its final omnibus spending bill.

Medicare was the primary payer for 90 percent of transcatheter aortic valve replacement (TAVR) hospitalizations over a recent three-year period, according to a March 19 report in JACC: Cardiovascular Interventions. With that in mind, the recent proposal to cut $473 billion from the CMS budget over the next decade could limit access to the increasingly popular procedure, researchers noted.

Linda Gates-Striby raised some eyebrows at the American College of Cardiology’s Cardiovascular Summit in February when, in one PowerPoint slide, she showed how much proper documentation and coding could affect a hospital’s quality measures, bottom line—and even a doctor’s reputation.

Siemens’ healthcare division, Siemens Healthineers, began trading on Germany’s stock exchange Friday, raising $5.2 billion (4.2 billion euros) by selling 15 percent of the company. Shares of were issued at 28 euros each but opened at 29.10 euros each.

Women outpaced men in medical school enrollment for the first time in 2017, but a new report shows they’re entering a profession where the gender pay gap is only growing.